stock
ATTO · Attovia Therapeutics, Inc.
What Attovia Therapeutics, Inc. reports to the SEC, read from its filings.
Open in the appPrice
The live ATTO price and today's change.
Sign in to see thisChart
Thirty days of daily bars, with signal levels drawn on them.
Sign in to see thisSignals
The latest signal group Nakagai's scanner recorded on ATTO.
Sign in to see thisOptions positioning
Gamma exposure levels from the options market.
Sign in to see thisTechnicals
Trend, momentum and volatility gauges per timeframe.
Sign in to see thisWhat it is
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Filer (SEC EDGAR)
- EDGAR filing index
- Shares outstanding
- 45,651,262 as of 2026-08-31 (XBRL frame CY2026Q3I)
Key stats
Valuation
- P/E
- Locked
- P/S
- Locked
- P/B
- Locked
- Enterprise value
- Locked
- EV/EBIT
- Locked
- FCF yield
- Locked
Margins
- Gross
- —
- Operating
- —
- Net
- —
Returns
- ROE
- —
- ROA
- —
Health
- Current ratio
- 9.4x
- Debt/equity
- —
Deep value
- NCAV
- $102.82M
- NCAV per share
- $2.25
- Price/NCAV
- Locked
- NNWC
- $17.25M
- NNWC per share
- $0.38
- Price/NNWC
- Locked
Valuation and the price multiples are built on the live price. Trailing twelve months to —; balance sheet at 2026-06-30.
Sign in to see thisDebt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.
Results
| Period end | Revenue | Gross profit (not reported by this company) | Operating income | Net income | Filing |
|---|---|---|---|---|---|
| 2026-06-30 | $450,000 | —Gross profit: unreported by this company. | -$21.80M | -$20.69M | 10-Q filed 2026-09-02 |
| 2026-03-31 | — | —Gross profit: unreported by this company. | — | -$18.66M | 10-Q filed 2026-09-02 |
| 2025-06-30 | $0 | —Gross profit: unreported by this company. | -$16.62M | -$14.44M | 10-Q filed 2026-09-02 |
| 2025-03-31 | — | —Gross profit: unreported by this company. | — | -$15.15M | 10-Q filed 2026-09-02 |
- Assets
- $128.35M
- Equity
- -$145.46M
Balance as of 2026-06-30.
Ten years
No annual results reported by SEC for this filer.
Company filings
1 offering filing in 12 months
5% owners ()
Deep Track Capital, LP
Passive stake
Frazier Life Sciences Public Fund, L.P.
Activist stake
Insiders, politicians and funds
Insider trades, last 90 days
WALSH COLIN
Director
Sale$2,251,658Aug 28, 5:38 PM ET
WALSH COLIN
Director
Buy$10,285,000Aug 28, 5:38 PM ET
GOLDMAN SACHS GROUP INC
Insider
Sale$2,251,658Aug 28, 5:38 PM ET
GOLDMAN SACHS GROUP INC
Insider
Buy$10,285,000Aug 28, 5:38 PM ET
WALSH COLIN
Director
Sale$2,251,658Aug 13, 9:52 PM ET
Politician trades, last 90 days
No politician trades filed in the last 90 days.
Funds
None of the tracked funds held this at their last 13F.
News
Stories that named ATTO, and the market events around them.
Sign in to see thisBoard
Recent signals
Signals open up here once a member has posted about ATTO.
Signals are informational.
Posts · 0
No posts yet.
nakagai
Signals on ATTO come from a rule, not a model.
Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.
Members post on the ATTO board